Furthermore, some rheumatoid arthritis patients undergoing therapy with anti-TNF-ɑ agents develop new-onset glomerular disease caused by pauci-immune necrotizing and crescentic glomerulonephritis, membranous nephropathy, or IgA nephropathy [27–29]. This evidence concerns the gene TNF and membranous glomerulonephritis.